GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...

GSK and Oxford researchers to create cancer vaccine to stop disease developing - GSK will invest up to £50 million in the new ...

Pharmaceutical giant GSK and the University of Oxford are collaborating on developing a cancer vaccine that aims to detect ...

GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...

The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...

Scientists at Oxford University, which pioneered Covid-19 vaccines, turn attention to ‘detecting the undetectable’ and ...

Global biopharma company GSK has invested up to £50 million in a collaboration with Oxford University. The agreement establishes the GSK-Oxford Cancer Immuno-Prevention Programme, aimed at exploring ...

GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...

Scientists at Oxford University and drugmaker GSK to ‘detect the undetectable’ and identify changes in cells that start up to ...

GSK plc and the University of Oxford (Oxford) announced that they have entered a new research collaboration focused on the potential of cancer prevention through vaccination. The GSK-Oxford Cancer ...

Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...